Work

Supplementary Figure Legends from A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer

Year: 2023
Type: supplementary-materials
Abstract: Supplementary figures titles and legends are placed in this document
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361887564
Cites:
Cited by:
Related to: 10